Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of UPJ stenosis requiring surgical repair~* Ages 3 months to 14 years old~* Guardians give consent and the child gives assent when appropriate~* Both genders~* All racial and ethnic groups~Exclusion Criteria:~* A history of chronic pain and/or use of chronic opioids and other analgesic(s)~* If parents/patients or attending urologist request epidural analgesia or refuse to participate in the study~* Impairment of cognition/neurologic, hepatic, renal, cardiovascular, endocrine, metabolic, and/or coagulation function~* A history of any diagnosis of psychiatric disorders, including bipolar disorders by self-report or by guardian~* A recent history of illicit chemical abuse within one week prior to surgical date~* Participants known to be taking prescribed medications or over-the-counter medications known to affect pain perception such as central nervous system stimulants, hypnotics, sedatives, etc within 24 hours of planned surgical procedure

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Ropivacaine group (Type: ACTIVE_COMPARATOR): Patients in this group will receive ropivacaine via the wound catheter for the first 48hrs after surgery
- Normal Saline Group (Type: PLACEBO_COMPARATOR): Will receive an infusion of normal saline for 48hrs post-operatively via the wound catheter.

Based on this trial design, predict the completion outcome and termination type (if applicable).